SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for BIO KEY INTERNATIONAL INC (BKYI) (CIK 0001019034) (BKYI) — Dec 31, 2013

BIO KEY INTERNATIONAL INC (BKYI) (CIK 0001019034)
Date: Dec. 31, 2013 · CIK: 0001019034 · Accession: 0000000000-13-070774

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
December 31, 2012
Author
/s/ Matthew Crispino
Form
UPLOAD
Company
BIO KEY INTERNATIONAL INC (BKYI) (CIK 0001019034)

Letter

December 31 , 2013 Via E -mail Michael W. DePasquale Chief Executive Officer BIO-Key International, Inc. 3349 Highway 138, Building A, Suite E Wall, NJ 07719

Re: BIO-Key International, Inc. Form 10 -K for Fiscal Year Ended December 31, 2012 Filed April 1, 2013 File No. 001 -13463

Dear Mr. DePasquale :

We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the Unite d States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Matthew Crispino

Show Raw Text
December 31 , 2013

Via E -mail
Michael W. DePasquale
Chief Executive Officer
BIO-Key International, Inc.
3349 Highway 138, Building A, Suite E
Wall, NJ 07719

Re: BIO-Key International, Inc.
Form 10 -K for Fiscal Year Ended December 31, 2012
Filed April 1, 2013
  File No. 001 -13463

Dear Mr. DePasquale :

We have completed our review of your filing .  We remind you that our comments or
changes to disclosure in response to our comments do not  foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the Unite d States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

 /s/ Matthew Crispino

Matthew Crispino
Staff Attorney

cc: Via E -mail
Vincent A. Vietti, Esq.
 Fox Rothschild LLP